相关实验视频
Updated: Jul 25, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.4K
在患有支气管喘的患者中出现的炎症标志物和心声指数
Nikolaos A Gkavogiannakis1,2, James N Tsoporis3, Ioannis-Alexandros Drosatos4,5
1Allergy Unit "D. Kalogeromitros", Attikon University Hospital, 124 62 Athens, Greece.
Biomolecules
|June 28, 2023
概括
这项研究发现,喘患者的IL-6和AGE水平较高,DJ-1水平较低. 用皮质类固醇/β2-激动剂治疗使这些水平正常化,这表明DJ-1和AGE/RAGE比率是喘的潜在生物标志物.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
背景情况:
- 喘涉及呼吸道炎症和氧化应激,其中包括RAGE激活等途径.
- 在喘患者中观察到心脏功能异常.
- DJ-1是一种对氧化还原敏感的蛋白质,在杆细胞平衡和喘发病过程中发挥作用.
研究的目的:
- 在治疗前和治疗后,对喘患者的RAGE,它的配体和DJ-1的血水平进行调查.
- 为了将这些分子标记与心血管功能回声心脏学指数相关联.
主要方法:
- 他们测量了RAGE,AGE,S100A12,S100B,S100A8/A9,IL-6,IL-1β和DJ-1的血水平.
- 对13名新诊断的喘患者和12名对照患者进行了心声扫描.
- 喘患者接受了皮质类固醇/β2抗原剂治疗.
主要成果:
- 与对照组相比,喘患者的IL-6,AGE和AGE/RAGE比率增加,S100A12和DJ-1水平降低.
- 两组之间没有观察到心声回声指数的基线差异.
- 治疗减少了IL-6和AGE,并增加了DJ-1水平.
结论:
- 血S100A12,AGE/sRAGE比率,DJ-1和IL-6可以作为诊断和治疗喘的有用工具.
- 随着喘治疗,DJ-1水平增加,这表明其作为治疗标或生物标记物的潜力.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

